Variant report

Variant	esv3493308
Chromosome Location	chr12:123187437-123200966
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:86)
CpG islands
(count:489)
Chromatin interactive
region (count:2)
LncRNA
region (count:3)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:86 , 50 per page) page: 1 2

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BATF	chr12:123198368-123198752	GM12878	blood:	n/a	n/a
2	BATF	chr12:123198415-123198667	GM12878	blood:	n/a	n/a
3	BCL11A	chr12:123198389-123198642	GM12878	blood:	n/a	chr12:123198604-123198613
4	CBX3	chr12:123192855-123193151	K562	blood:	n/a	n/a
5	CEBPB	chr12:123192061-123192396	A549	lung:	n/a	chr12:123192205-123192216
6	CEBPB	chr12:123187833-123188233	Hela-S3	cervix:	n/a	n/a
7	CEBPB	chr12:123194984-123195338	MCF-7	breast:	n/a	n/a
8	CEBPB	chr12:123187869-123188146	A549	lung:	n/a	n/a
9	CEBPB	chr12:123187794-123188089	HepG2	liver:	n/a	n/a
10	CEBPB	chr12:123192059-123192377	IMR90	lung:	n/a	chr12:123192205-123192216
11	CEBPB	chr12:123192060-123192294	HepG2	liver:	n/a	chr12:123192205-123192216
12	CEBPB	chr12:123192177-123192277	Hela-S3	cervix:	n/a	chr12:123192205-123192216
13	CEBPB	chr12:123192198-123192210	H1-hESC	embryonic stem cell:	n/a	n/a
14	E2F4	chr12:123187896-123188134	MCF10A-Er-Src	breast:	n/a	n/a
15	EBF1	chr12:123187913-123188259	GM12878	blood:	n/a	n/a
16	EBF1	chr12:123187949-123188264	GM12878	blood:	n/a	n/a
17	EP300	chr12:123187789-123188123	HepG2	liver:	n/a	n/a
18	FOS	chr12:123187706-123188305	MCF10A-Er-Src	breast:	n/a	n/a
19	FOS	chr12:123187796-123188158	MCF10A-Er-Src	breast:	n/a	n/a
20	FOS	chr12:123187570-123188311	MCF10A-Er-Src	breast:	n/a	n/a
21	FOS	chr12:123187821-123188180	MCF10A-Er-Src	breast:	n/a	n/a
22	FOSL2	chr12:123198037-123198405	HepG2	liver:	n/a	chr12:123198238-123198246 chr12:123198236-123198247 chr12:123198236-123198248 chr12:123198241-123198248
23	FOSL2	chr12:123193878-123194221	HepG2	liver:	n/a	n/a
24	FOXA1	chr12:123187806-123188302	HepG2	liver:	n/a	n/a
25	FOXA1	chr12:123187829-123188220	HepG2	liver:	n/a	n/a
26	FOXA2	chr12:123187936-123188118	HepG2	liver:	n/a	n/a
27	GATA2	chr12:123192789-123193089	K562	blood:	n/a	n/a
28	GATA2	chr12:123194868-123195095	SH-SY5Y	brain:	n/a	n/a
29	GATA3	chr12:123194991-123195209	MCF-7	breast:	n/a	n/a
30	GATA3	chr12:123193377-123193611	T-47D	breast:	n/a	n/a
31	GATA3	chr12:123194628-123195408	MCF-7	breast:	n/a	n/a
32	GATA3	chr12:123194897-123195387	MCF-7	breast:	n/a	n/a
33	HDAC2	chr12:123194915-123195367	MCF-7	breast:	n/a	n/a
34	HEY1	chr12:123187714-123188013	HepG2	liver:	n/a	n/a
35	IRF4	chr12:123198309-123198803	GM12878	blood:	n/a	n/a
36	IRF4	chr12:123198054-123198813	GM12878	blood:	n/a	n/a
37	JUND	chr12:123198141-123198327	HepG2	liver:	n/a	chr12:123198238-123198246 chr12:123198236-123198247 chr12:123198236-123198248 chr12:123198241-123198248
38	JUND	chr12:123198163-123198298	HepG2	liver:	n/a	chr12:123198238-123198246 chr12:123198236-123198247 chr12:123198236-123198248 chr12:123198241-123198248
39	JUND	chr12:123194874-123195301	MCF-7	breast:	n/a	n/a
40	MYC	chr12:123187750-123188250	MCF10A-Er-Src	breast:	n/a	n/a
41	MYC	chr12:123187728-123188305	MCF10A-Er-Src	breast:	n/a	n/a
42	NFIC	chr12:123198230-123198801	GM12878	blood:	n/a	n/a
43	NR2F2	chr12:123192809-123193203	K562	blood:	n/a	n/a
44	NR2F2	chr12:123194844-123195369	MCF-7	breast:	n/a	n/a
45	NR2F2	chr12:123194900-123195374	MCF-7	breast:	n/a	n/a
46	PAX5	chr12:123198298-123198672	GM12878	blood:	n/a	chr12:123198604-123198613
47	POLR2A	chr12:123187462-123188263	MCF10A-Er-Src	breast:	n/a	n/a
48	POLR2A	chr12:123187757-123187873	HepG2	liver:	n/a	n/a
49	POLR2A	chr12:123193902-123193996	MCF-7	breast:	n/a	n/a
50	POLR2A	chr12:123187704-123188015	Hela-S3	cervix:	n/a	n/a

(count:489 , 50 per page) page: 1 2 3 4 5 6 7 ... 10

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr12:123200953-123201003	AG04450	lung:	fetal
2	chr12:123200953-123201003	AG04450	lung:	fetal
3	chr12:123188078-123188128	HEK293	kidney:	embryo
4	chr12:123200953-123201003	SKMC	muscle:	n/a
5	chr12:123200953-123201003	LNCaP	prostate:	n/a
6	chr12:123200953-123201003	PFSK-1	brain:	n/a
7	chr12:123189236-123189286	HCPEpiC	choroid plexus:	n/a
8	chr12:123200533-123200583	NHBE	bronchial:	n/a
9	chr12:123189256-123189306	PFSK-1	brain:	n/a
10	chr12:123187474-123187524	CMK	blood:	n/a
11	chr12:123188078-123188128	HRPEpiC	eye:	n/a
12	chr12:123189256-123189306	GM12892	blood:	n/a
13	chr12:123200953-123201003	ECC-1	luminal epithelium:	n/a
14	chr12:123188078-123188128	T-47D	breast:	n/a
15	chr12:123200953-123201003	K562	blood:	n/a
16	chr12:123187474-123187524	SK-N-SH_RA	brain:	n/a
17	chr12:123187474-123187524	AG09309	skin:	n/a
18	chr12:123200533-123200583	ECC-1	luminal epithelium:	n/a
19	chr12:123188078-123188128	HepG2	liver:	n/a
20	chr12:123189256-123189306	HRCEpiC	kidney:	n/a
21	chr12:123189236-123189286	BJ	skin:	n/a
22	chr12:123187529-123187579	A549	lung:	n/a
23	chr12:123188078-123188128	SK-N-SH_RA	brain:	n/a
24	chr12:123187474-123187524	RPTEC	kidney:	n/a
25	chr12:123189256-123189306	CMK	blood:	n/a
26	chr12:123200353-123200403	HNPCEpiC	eye:	n/a
27	chr12:123200353-123200403	HepG2	liver:	n/a
28	chr12:123200353-123200403	AG09309	skin:	n/a
29	chr12:123187529-123187579	HIPEpiC	eye:	n/a
30	chr12:123188078-123188128	HCM	heart:	n/a
31	chr12:123200953-123201003	MCF-7	breast:	n/a
32	chr12:123200353-123200403	GM12878	blood:	n/a
33	chr12:123188078-123188128	HMEC	breast:	n/a
34	chr12:123200953-123201003	GM06990	blood:	n/a
35	chr12:123200533-123200583	MCF10A-Er-Src	breast:	n/a
36	chr12:123200533-123200583	PANC-1	pancreas:	n/a
37	chr12:123200533-123200583	GM12892	blood:	n/a
38	chr12:123188078-123188128	HNPCEpiC	eye:	n/a
39	chr12:123200533-123200583	H1-hESC	embryonic stem cell:	embryo
40	chr12:123200953-123201003	AG04449	skin:	fetal
41	chr12:123189236-123189286	AoSMC	blood vessel:	n/a
42	chr12:123189236-123189286	HEK293	kidney:	embryo
43	chr12:123200533-123200583	NT2-D1	testis:	n/a
44	chr12:123200353-123200403	AG09319	gingival:	n/a
45	chr12:123200353-123200403	AG04450	lung:	fetal
46	chr12:123187529-123187579	HMEC	breast:	n/a
47	chr12:123187529-123187579	GM12878	blood:	n/a
48	chr12:123187474-123187524	PANC-1	pancreas:	n/a
49	chr12:123200533-123200583	GM06990	blood:	n/a
50	chr12:123187529-123187579	K562	blood:	n/a

(count:2 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr12:123186486..123188573-chr12:123199930..123201817,2	MCF-7	breast:
2	chr12:123186486..123188573-chr12:123199930..123201817,2	MCF-7	breast:

(count:3 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-DENR-2	chr12:123198838-123199340	ENSG00000256249
2	lnc-DENR-2	chr12:123199801-123200187	NONHSAT031529
3	lnc-DENR-2	chr12:123200008-123200255	ENSG00000256249

No data

Variant related genes	Relation type
HCAR2	TF binding region
ENSG00000256249	TF binding region
HCAR2	CpG island
ENSG00000256249	CpG island
ENSG00000182782	chromatin interactions
ENSG00000255398	chromatin interactions
GALNT11	miRNA target sites
LRRC41	miRNA target sites

Extended variants
information (count: 663 )
Associated
traits (count: 68 )

Variant overlapped rSNPs/rCNVs (count:663 , 50 per page) page: 1 2 3 4 5 6 7 ... 14

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs200794872	chr12:123187443-123187444	Enhancers Weak transcription Flanking Active TSS Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
2	rs200534953	chr12:123187448-123187449	Enhancers Weak transcription Flanking Active TSS Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
3	rs201756503	chr12:123187449-123187450	Enhancers Weak transcription Flanking Active TSS Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
4	rs138078446	chr12:123187450-123187451	Enhancers Weak transcription Flanking Active TSS Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
5	rs371493470	chr12:123187458-123187459	Enhancers Weak transcription Flanking Active TSS Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
6	rs375811004	chr12:123187465-123187466	Enhancers Weak transcription Flanking Active TSS Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
7	rs200705418	chr12:123187466-123187467	Enhancers Weak transcription Flanking Active TSS Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
8	rs202043479	chr12:123187475-123187476	Enhancers Weak transcription Flanking Active TSS Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
9	rs199839290	chr12:123187480-123187481	Enhancers Weak transcription Flanking Active TSS Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
10	rs201162226	chr12:123187483-123187484	Enhancers Weak transcription Flanking Active TSS Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
11	rs115977736	chr12:123187507-123187508	Enhancers Weak transcription Flanking Active TSS Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
12	rs144981479	chr12:123187514-123187515	Enhancers Weak transcription Flanking Active TSS Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
13	rs370020427	chr12:123187521-123187522	Enhancers Weak transcription Flanking Active TSS Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
14	rs200146945	chr12:123187524-123187525	Enhancers Weak transcription Flanking Active TSS Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
15	rs200794525	chr12:123187530-123187531	Enhancers Weak transcription Flanking Active TSS Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
16	rs138786161	chr12:123187541-123187542	Enhancers Weak transcription Flanking Active TSS Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
17	rs201792054	chr12:123187547-123187548	Enhancers Weak transcription Flanking Active TSS Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
18	rs200252776	chr12:123187562-123187563	Enhancers Weak transcription Flanking Active TSS Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
19	rs201453681	chr12:123187568-123187569	Enhancers Weak transcription Flanking Active TSS Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
20	rs528311075	chr12:123187573-123187574	Enhancers Weak transcription Flanking Active TSS Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
21	rs202234525	chr12:123187576-123187577	Enhancers Weak transcription Flanking Active TSS Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
22	rs141964528	chr12:123187596-123187597	Enhancers Weak transcription Flanking Active TSS Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
23	rs201537980	chr12:123187599-123187600	Enhancers Weak transcription Flanking Active TSS Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
24	rs143690784	chr12:123187603-123187604	Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
25	rs148119862	chr12:123187606-123187607	Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
26	rs200828023	chr12:123187618-123187619	Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
27	rs201489597	chr12:123187623-123187624	Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
28	rs141935401	chr12:123187628-123187629	Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
29	rs200608306	chr12:123187640-123187641	Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
30	rs201770856	chr12:123187643-123187644	Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
31	rs530458347	chr12:123187647-123187648	Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
32	rs200200672	chr12:123187711-123187712	Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
33	rs200648444	chr12:123187731-123187732	Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
34	rs150676604	chr12:123187735-123187736	Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
35	rs200069147	chr12:123187738-123187739	Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
36	rs141014410	chr12:123187739-123187740	Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
37	rs200149127	chr12:123187749-123187750	Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
38	rs143364253	chr12:123187750-123187751	Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
39	rs550295867	chr12:123187751-123187752	Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
40	rs375289216	chr12:123187755-123187756	Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
41	rs568545263	chr12:123187759-123187760	Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
42	rs201865940	chr12:123187788-123187789	Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
43	rs199911863	chr12:123187793-123187794	Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
44	rs201158846	chr12:123187797-123187798	Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
45	rs202092973	chr12:123187801-123187802	Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
46	rs200636697	chr12:123187813-123187814	Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
47	rs147537296	chr12:123187816-123187817	Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
48	rs140256769	chr12:123187823-123187824	Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
49	rs200260573	chr12:123187824-123187825	Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
50	rs201425132	chr12:123187836-123187837	Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:68)

Disease	PMID	Source
Esophageal cancer	21851588	CNVD
Lung cancer	20668451	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Ewing''s sarcoma	21437220	CNVD
Testicular germ cell tumor	18059402	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Medulloblastoma	21979893	CNVD
Malaria	21533027	CNVD
Chronic lymphocytic leukemia	22228453	CNVD
Basal cell lymphoma	17053054	CNVD
Chronic lymphocytic leukemia	21670202	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Hodgkin''s lymphoma	17606441	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Breast cancer	21949216	CNVD
Carcinoma ex pleomorphic adenoma	18828159	CNVD
Acute myeloid leukemia	16864856	CNVD
Cancer	21637783	CNVD
Glioblastoma multiforme	21080181	CNVD
Renal cell carcinoma	19461508	CNVD
Burkitt''s lymphoma	18698080	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Gastrointestinal stromal cancer	20470368	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Lung cancer	18438408	CNVD
small cell lung cancer	20016488	CNVD
Glioblastoma multiforme	21390271	CNVD
Cancer	20164919	CNVD
Cancer	16751803	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
Wilms tumour	21544195	CNVD
Ovarian cancer	21720365	CNVD
Colorectal cancer	16272173	CNVD
lymphocytic leukemia	21291569	CNVD
Breast cancer	16397240	CNVD
Breast cancer	17133270	CNVD
Breast cancer	17603634	CNVD
Gastrointestinal stromal cancer	20877625	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Schizophrenia	18923514	CNVD
Schizophrenia	22241247	CNVD
Cryptorchidism	21048976	CNVD
Myeloproliferative neoplasm	20015882	CNVD
Neuroblastoma	18923191	CNVD
Medulloblastoma	16783165	CNVD
Breast cancer	21806811	CNVD
Non-syndromic sensorineural hearing loss	18496225	CNVD
Prostate cancer	18632612	CNVD
Myelofibrosis	22110671	CNVD
Beckwith-Wiedemann syndrome	20648245	CNVD
Developmental delay	21457577	CNVD
dysmorphic	21457577	CNVD
Ovine squamous-cell carcinoma	17599052	CNVD
Olfactory neuroblastoma	18408657	CNVD
Chordoma	18071362	CNVD

Chromatin state (count:128 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr12:123166600-123187800	Weak transcription	A549	lung
2	chr12:123174000-123199800	Weak transcription	Breast Myoepithelial Primary Cells	Breast
3	chr12:123184000-123188800	Enhancers	Primary monocytes fromperipheralblood	blood
4	chr12:123185400-123188200	Active TSS	Primary B cells from cord blood	blood
5	chr12:123186000-123188000	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
6	chr12:123186000-123188000	Enhancers	Placenta	Placenta
7	chr12:123186000-123188200	Enhancers	NHEK	skin
8	chr12:123186000-123188600	Flanking Active TSS	Primary neutrophils fromperipheralblood	blood
9	chr12:123186000-123188600	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
10	chr12:123186800-123187800	Weak transcription	Foreskin Fibroblast Primary Cells skin02	Skin
11	chr12:123186800-123188000	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
12	chr12:123187000-123188000	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
13	chr12:123187200-123187600	Flanking Active TSS	Esophagus	oesophagus
14	chr12:123187200-123187800	Flanking Active TSS	Adipose Nuclei	Adipose
15	chr12:123187400-123187600	Flanking Active TSS	Foreskin Keratinocyte Primary Cells skin02	Skin
16	chr12:123187400-123187800	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
17	chr12:123187400-123187800	Enhancers	Spleen	Spleen
18	chr12:123187400-123188000	Enhancers	HMEC	breast
19	chr12:123187400-123188200	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
20	chr12:123187400-123188600	Enhancers	Hela-S3	cervix
21	chr12:123187600-123187800	Active TSS	Foreskin Keratinocyte Primary Cells skin02	Skin
22	chr12:123187600-123187800	Active TSS	Esophagus	oesophagus
23	chr12:123187600-123187800	Enhancers	Fetal Thymus	thymus
24	chr12:123187600-123188200	Bivalent Enhancer	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
25	chr12:123187600-123188200	Enhancers	HepG2	liver
26	chr12:123187800-123188000	Enhancers	Foreskin Fibroblast Primary Cells skin02	Skin
27	chr12:123187800-123188000	Flanking Active TSS	Foreskin Keratinocyte Primary Cells skin02	Skin
28	chr12:123187800-123188000	Enhancers	A549	lung
29	chr12:123187800-123198600	Weak transcription	Adipose Nuclei	Adipose
30	chr12:123188000-123193600	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
31	chr12:123188200-123188600	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
32	chr12:123188200-123188800	Enhancers	Primary B cells from cord blood	blood
33	chr12:123188200-123192000	Weak transcription	HepG2	liver
34	chr12:123188600-123188800	Enhancers	Monocytes-CD14+_RO01746	blood
35	chr12:123188600-123190400	Enhancers	Primary neutrophils fromperipheralblood	blood
36	chr12:123190400-123195000	Weak transcription	Primary neutrophils fromperipheralblood	blood
37	chr12:123192000-123192600	Enhancers	HepG2	liver
38	chr12:123192600-123199800	Weak transcription	HepG2	liver
39	chr12:123193600-123193800	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
40	chr12:123193800-123194200	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
41	chr12:123194200-123194800	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
42	chr12:123194400-123195600	Enhancers	Placenta	Placenta
43	chr12:123194400-123196000	Enhancers	NHEK	skin
44	chr12:123194600-123195200	Enhancers	Fetal Intestine Large	intestine
45	chr12:123194800-123195800	Enhancers	HMEC	breast
46	chr12:123195000-123195400	Enhancers	Primary neutrophils fromperipheralblood	blood
47	chr12:123195000-123195400	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
48	chr12:123195000-123195600	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
49	chr12:123195000-123195600	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
50	chr12:123195400-123196000	Enhancers	Monocytes-CD14+_RO01746	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links